SCHEMBL7685932

SCHEMBL7685932

CCCCCCCC(C)OC(=O)C(CC)(CC)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.49
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
ALDH1A1 P00352 1/20 0.47
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
GPR84 Q9NQS5 4/20 0.41
FFAR1 O14842 1/20 0.41
NAAA Q02083 1/20 0.40
MAPT P10636 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
HSPD1 P10809 1/20 0.39
BLM P54132 1/20 0.39
HSPE1 P61604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182927 1.00 FAAH (0.49) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL14645473 1.00 FAAH (0.49) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL7681787 0.93 FAAH (0.41) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL5570199 0.93 FAAH (0.41) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL7685929 0.92 FAAH (0.53) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL7998405 0.89 FAAH (0.48) FAAHCNR1CNR2ALDH1A1KDM4E
SCHEMBL8404113 0.86 CHRM1 (0.34) FAAHCNR1CNR2ALDH1A1
SCHEMBL7681782 0.84 FAAH (0.44) FAAHCNR1CNR2ALDH1A1NAAA
SCHEMBL27939909 0.84 FAAH (0.38) FAAHCNR1CNR2ALDH1A1MAPT
SCHEMBL7783740 0.83 GPR84 (0.40) KMT2AACE2GPR84FFAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384279-B1 OXIDIZING A DIAMIDODIOL TO FORM A DIACID FOLLOWED BY COUPLING WITH AN ARYL DIAMINE THE CLOROX COMPANY 2002-05-07 US disclosed
US-20020028970-A1 SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL THE CLOROX COMPANY 2002-03-07 US disclosed
US-6297400-B1 CHELATING AGENTS FOR IMPROVED WASHFASTNESS OF DYE WHEN IN A BLEACHING ENVIRONMENT THE CLOROX COMPANY 2001-10-02 US disclosed
WO-2001002343-A1 IMPROVED SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL THE CLOROX COMPANY (US) 2001-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028970-A1 SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL DDT, DDC, MLYCD FAAH 2554/4885CNR1 1142/4885CNR2 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.